Finding HDV in Turkey Study
Part of Cancer, Digestive system, Infections clinical trials.
This trial is looking for adults in Turkey who have had a hepatitis B infection (HBsAg positive) for at least 6 months. The goal is to see if they also have a hepatitis D virus (HDV) infection. This may help doctors better understand and treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have tested positive for hepatitis B surface antigen (HBsAg) for at least 6 months.
- You are a citizen of the Republic of Turkey.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, Libevitug, for people with chronic hepatitis D (HDV). It aims to see if the drug can help control the virus and improve liver health.
This trial is testing treatments for people with chronic hepatitis D, a serious liver infection. If you have antibodies to the hepatitis D virus (HDV), you may be able to join and help find better ways to manage this condition.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
This study looks at patient information (your health data) for adults who test positive for HDV. You may help researchers better understand HDV by allowing their team to collect and use your data.
This study follows adults with long-term (chronic) hepatitis B to better understand the condition over time. If you have chronic hepatitis B, it may help researchers improve care for people with the infection.
This is a registry-based study that collects information from adults who have hepatitis D infection confirmed by a positive RNA test. It may help researchers better understand hepatitis D in real-world patients and guide future care.
Hear when a new Chronic Hepatitis D Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.